Mersana Therapeutics
A biopharmaceutical company focused on the development of oncology therapeutics
All edits by Cameron Porter
Edits on 30 Apr, 2019
Cameron Porter
Edits made to:
Article (+20/-20 characters)
Article
On November 8, 2005 Mersana Therapeutics completed a venture capital round with 421 million in funding from ProQuest Investments (lead investor), F-Prime Capital Partners (lead Investor), Rho Capital Partners, PureTech Health, Lansing Brown Investments, Eight Roads VenturesEight Roads Ventures, Cape Family Fund, and 180 degree Capital.
Find more companies like Mersana Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.